ORINY (Orion Oyj) Common Stock : $97 Mil (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Orion Oyj Common Stock?

Orion Oyj's quarterly common stock increased from Jun. 2024 ($99 Mil) to Sep. 2024 ($102 Mil) but then declined from Sep. 2024 ($102 Mil) to Dec. 2024 ($97 Mil).

Orion Oyj's annual common stock increased from Dec. 2022 ($98 Mil) to Dec. 2023 ($101 Mil) but then declined from Dec. 2023 ($101 Mil) to Dec. 2024 ($97 Mil).

Orion Oyj Common Stock Historical Data

The historical data trend for Orion Oyj's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Oyj Common Stock Chart

Orion Oyj Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Common Stock

Get a 7-Day Free Trial

112.17

104.18

97.67

100.55

96.55

Orion Oyj Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															100.55	100.22	99.25	102.33	96.55

Orion Oyj Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Orion Oyj Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (OTCPK:ORINY) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

ORNBVh:UK 0M2O:UK 0M2N:UK ORNBV:Finland ORNAV:Finland OFK:Germany

Address

Orionintie 1, Espoo, FIN, FI-02200

Website

https://www.orion.fi

Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.